Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Receivables - Net (2013 - 2026)

Innoviva's (INVA) quarterly Receivables - Net came in at $34.0 million in Q1 2026, up 103.95% YoY from $16.7 million in Q1 2025, and down 41.72% on a QoQ basis from $58.4 million in Q4 2025.

Analysis

Innoviva (INVA) Receivables - Net (2013 - 2026) Analysis & Trends

Innoviva (INVA) has 7 years of Receivables - Net data on file, last reported at $34.0 million in Q1 2026.

  • Quarterly Receivables - Net rose 103.95% year-over-year to $34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.0 million (up 103.95% YoY) and the FY2025 annual result came in at $58.4 million, down 11.55% from the prior year.
  • Receivables - Net declined to $34.0 million in Q1 2026, from $58.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $69.6 million in Q4 2023 to a low of $6.7 million in Q3 2022.
  • A 5-year average of $41.6 million and a median of $54.7 million in 2022 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2023 — Receivables - Net surged 745.53% — and 2024, when it sank 76.56%.
  • Tracing INVA's Receivables - Net over 5 years: stood at $54.7 million in 2022, then grew by 27.34% to $69.6 million in 2023, then retreated by 5.24% to $66.0 million in 2024, then decreased by 11.55% to $58.4 million in 2025, then tumbled by 41.72% to $34.0 million in 2026.
  • The last three Receivables - Net figures came in at $34.0 million (Q1 2026), $58.4 million (Q4 2025), and $63.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.79 Mn
Mar 31, 2026 58.62 Mn
Dec 31, 2025 58.35 Mn
Sep 30, 2025 63.35 Mn
Jun 30, 2025 67.34 Mn
Mar 31, 2025 61.26 Mn
Dec 31, 2024 65.97 Mn
Sep 30, 2024 60.51 Mn
Jun 30, 2024 67.20 Mn
Mar 31, 2024 61.87 Mn
Dec 31, 2023 69.62 Mn
Sep 30, 2023 57.01 Mn
Jun 30, 2023 65.72 Mn
Mar 31, 2023 60.31 Mn
Dec 31, 2022 54.67 Mn
Sep 30, 2022 6.74 Mn
Dec 31, 2021 110.71 Mn
Mar 31, 2014 3,000.00
Dec 31, 2013 199,000.00
Sep 30, 2013 450,000.00